Conferences - Results from #9460

CUA 2017: Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer June 25, 2017

CUA 2017: Association Between Germline Genetic Variation and Progression in Men with Low-Risk Prostate Cancer on Active Surveillance June 25, 2017

CUA 2017: Prostate-Specific Antigen Levels in Men Aged 60-70 and Development of Lethal Prostate Cancer Over 30 Years: Implications for Risk-Stratified Screening June 25, 2017

CUA 2017: Defining a Cohort of Men Who May Not Require Repeat Prostate Biopsy Based on Negative Predictive Value of PCA3 and MRI Combined: The Double-Negative Effect June 25, 2017

CUA 2017: Chemotherapy and Novel Hormones in “Low Volume” Hormone-Sensitive Metastatic Prostate Cancer June 25, 2017

CUA 2017: Immuno-Oncology Update in Advanced Bladder Cancer June 25, 2017

CUA 2017: State of the Art Immunotherapy for Urologic Cancers. June 25, 2017

CUA 2017: Update on Bladder Preservation in Muscle Invasive Disease June 25, 2017

CUA 2017: PSMA-Targeted Radionuclide Therapies in Treatment of Prostate Cancer June 25, 2017

CUA 2017: The Role of Testosterone Nadir Levels in Androgen Deprivation Therapy June 25, 2017

CUA 2017: Optimizing Active Surveillance for Prostate Cancer June 25, 2017

CUA 2017: Role of MRI in Diagnosing Prostate Cancer June 25, 2017

CUA 2017: Role of Androgen Deprivation in Salvage Radiotherapy June 25, 2017

CUA 2017: Intraductal Prostate Cancer: Marker of Aggressive Disease? June 25, 2017

CUA 2017: Liquid Biopsy in Personalizing CRPC Therapy June 24, 2017

TAT-10: Efficacy of Actinium-225-labeled Anti-CD33 Antibody in Acute Myeloid Leukemia Correlates with Peripheral Blast Count June 21, 2017

TAT-10: Bi-213-anti-EGFR-Mab Therapy of Recurrent Bladder Cancer - A Pilot Study June 21, 2017

TAT-10: Targeted Alpha Therapy of Glioblastoma Multiforme: Clinical Experience with Bi213 and Ac225-Substance P June 21, 2017

TAT-10: Dosimetry and Biodistribution of Pb203-AR-RMX in Patients with Somatostatin Expressing Neuroendocrine Tumors: A Clinical Exploratory Study June 21, 2017

TAT-10: Ac225-PSMA-617: PSMA Targeting Alpha-Radiation Therapy of Patients with mCRPC June 21, 2017

Page 474 of 614